Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000642998 | SCV000764685 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440297 | SCV002752057 | uncertain significance | Cardiovascular phenotype | 2019-12-04 | criteria provided, single submitter | clinical testing | The p.A9876V variant (also known as c.29627C>T), located in coding exon 118 of the TTN gene, results from a C to T substitution at nucleotide position 29627. The alanine at codon 9876 is replaced by valine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004735698 | SCV005348614 | uncertain significance | TTN-related disorder | 2024-05-17 | no assertion criteria provided | clinical testing | The TTN c.56822C>T variant is predicted to result in the amino acid substitution p.Ala18941Val. This variant was reported in a healthy control but not affected individuals in a dilated cardiomyopathy case-control study (Table S4, Mazzarotto et al. 2020. PubMed ID: 31983221). This variant is reported in 0.0086% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |